To be able to use the full range of Shopware 6, we recommend activating Javascript in your browser.

+49 (0)6221 8278-0

info@progen.com

.hero-slider { overflow: auto !important; } .hero-slider, .hero-slider-slide-container { height: 60vh !important; } .hero-slider-image { width: 100% !important; height: auto !important; } .hero-slider { position: relative !important; } .hero-slider-image { position: static !important; } .hero-slider-scroll-overlay, .hero-slider-navigation-btn, .hero-slider-menu { display: none; }

NEW

Ultra-Sensitive Detection of Residual Nucleases

Explore the Endonuclease ELISA

High-quality Analytical Tools for Gene Therapy. Since 1983.

Find Analytical Tools

Keep it simple. Easy and reliable capsid titer determination with the AAV ELISA.

Shop AAV ELISAs

High-Quality Analytical Tools & Antibodies for Reliable Gene Therapy

Anti-AAVrh10 (intact particle) mouse monoclonal, PR10

An antibody for detecting intact AAVrh10 & AAVrh74 capsids.

View Antibody >

AAV Human Antibody ELISA (IgG)

An easy-to-use ELISA for multiple serotypes to accurately detect antibodies against AAV in blood samples.

Shop AAV Human Antibody ELISA >

AAV Titration ELISAs

Reliable AAV capsid titer determination – Standard and Xpress ELISAs available for a wide range of serotypes.

Shop AAV ELISAs >

Discover AAV Tools

AAV
ELISAs

AAV
Antibodies

AAV
Standards

AAV
OptiPrep^TM

AAV
Dip'n'Check

Shop AAV Products

High quality & established

Manufacturing antibodies since 1983. DIN EN ISO 13485 Certified and extensively published. All our AAV products are validated by international studies or rigorous internal gold standards.

Easy-to-use tools

Our AAV analytical tools are easy to implement into every workflow. No expensive equipment or special training needed. Products are optimized for a wide range of applications and ready-to-use.

Quick delivery worldwide

Made in Germany. Delivered worldwide. Our off-the-shelf AAV tools can be shipped immediately from Germany or our PROGEN Inc. subsidiary to ensure you get your analytical tools quickly and easily.

On-hand scientific support

We are a team of AAV experts and are partnered with gene therapy experts worldwide. On hand to support you in progressing new AAV gene therapies safely, quickly and affordably.

Events we are Attending

Advanced Therapies PROGEN is Attending

Advanced Therapies London

17 - 18 March 2026

Meet PROGEN at booth #29, check out our pan-AAV poster, and learn more about the upcoming Lenti p24 Assay.

Book an Appointment >

American Society of Gene and Cell therapy Event PROGEN is Attending

ASGCT Boston

11 - 15 May 2026

Seven new posters, new tools, and products on the horizon. Stop by to chat with the PROGEN team at booth #1633, or schedule a meeting beforehand.

Book an Appointment >

European Society of Gene and Cell therapy Event PROGEN is Attending

ESGCT Hamburg

27 - 30 October 2026

Meet us in Europe! Learn more about our latest products and how we can support your gene & cell therapy projects.

Book an Appointment >

"Our experience with PROGEN has been overwhelmingly positive and we are impressed with the lengths that PROGEN go to to make AAV related products successful. The PROGEN team are in constant communication and consultation with us and have exceeded our expectations. An extremely professional, remarkably responsive, and technically proficient team."

Lan Chen, Dakewe

News & Stories

Growing with PROGEN for More than Three Decades

Growing with PROGEN for More than Three Decades

Meet Anke Hoffmann (middle), who joined PROGEN in 1990. Working in product assembly and packaging, she interacts with almost every department.

From Vision to Legacy: Celebrating 42 Years of PROGEN

From Vision to Legacy: Celebrating 42 Years of PROGEN

In a lab in Heidelberg in 1983, a bold idea to develop new diagnostic reagents and test procedures took root. This October, we celebrate our 42nd anniversary of maintaining the spirit that gave birth to PROGEN and the future we have been creating.

Connecting Science and People

Connecting Science and People

Meet Account Manager Manja von Hahn, who helps scientists worldwide find the right solutions through open conversations and collaboration.

How We Became My Green Lab® Certified: Behind the Scenes at PROGEN

In a field where energy-intensive equipment, single-use plastics, and chemical waste are standard, we asked ourselves: Can we do better?

What We Took Home from ASGCT 2025: Science, Collaboration, and the Spirit of New Orleans

What We Took Home from ASGCT 2025: Science, Collaboration, and the Spirit of New Orleans

The 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in New Orleans was an event to remember for its scientific breakthroughs and the city's vibrant energy.

A Quick, Affordable Test for AAVs

A Quick, Affordable Test for AAVs

Elissa Hudspeth of North Carolina State University shares her experience using a test that has enabled her to more easily set up a manufacturing process for AAVs.

The Road to Transforming Medicine Through AAVs

The Road to Transforming Medicine Through AAVs

Adeno-associated virus (AAV) continues to lead the way in gene therapy research. Discover its evolution since the 1960s and its growing role in transforming treatments for both rare and common diseases.

Producing Reliable Products

Producing Reliable Products

Meet Head of Production Rita Lacher and discover how she contributes to transforming ideas into new products.

Top 5 Breakthroughs in LNP Research in 2024

Top 5 Breakthroughs in LNP Research in 2024

From overcoming blood-brain-barrier to more selective delivery, we've seen some truly exciting advancements in the LNP research field.

CRISPR/Cas Meets AAV: Navigating the Complexities of Gene Editing Delivery

CRISPR/Cas Meets AAV: Navigating the Complexities of Gene Editing Delivery

The Challenges and Limitations of In Vivo Delivery of CRISPR/Cas Gene Editing Tools

Science in Action

Science in Action

Meet Head of Research and Development Klaus-Ingmar Pfrepper and find out about his team’s recent discovery of a new AAV antibody.

Overcoming Liver Accumulation: Extrahepatic Targeting Strategies for Lipid Nanoparticles (LNPs)

Overcoming Liver Accumulation: Extrahepatic Targeting Strategies for Lipid Nanoparticles (LNPs)

New targeting strategies are showing how the accumulation of lipid nanoparticles (LNPs) in the liver can be reduced.

Beyond the Virus: How Non-Viral Vectors Are Changing Gene Therapy

Beyond the Virus: How Non-Viral Vectors Are Changing Gene Therapy

Lipid nanoparticles (LNPs), are emerging as promising non-viral vectors, offering distinct advantages that could make them integral to the future of gene therapy.

Five Challenges Of Applying Lipid Nanoparticles As Delivery Tools For Therapeutic Agents

Five Challenges Of Applying Lipid Nanoparticles As Delivery Tools For Therapeutic Agents

As effective as these delivery vehicles are, they come with their own set of difficulties.

Maximizing Efficiency

Maximizing Efficiency

Getting a transgene to be expressed inside the target cell is the name of the game.

Bringing New Products to Market

Bringing New Products to Market

Meet Product Manager Silja Adam, whose work on products is motivated by a desire to help customers meet their needs.

The Road To Even Safer AAV Gene Therapies

The Road To Even Safer AAV Gene Therapies

Although AAVs are among the safest gene therapy vectors, they do pose a few risks that can still be reduced.

Comparability Amid Change

Comparability Amid Change

When manufacturing changes bring challenges, standard reference materials can save the day.

Five Reasons to Choose Adeno-associated Viruses for Gene Therapy

Five Reasons to Choose Adeno-associated Viruses for Gene Therapy

These small but mighty DNA delivery vehicles are revolutionizing medicine.

Introducing Recombinant Adeno-associated Viruses (rAAV)

Introducing Recombinant Adeno-associated Viruses (rAAV)

Modifying AAVs makes them more efficient and better at targeting specific tissues.

Supporting the Gene Therapy Community

Supporting the Gene Therapy Community

Meet Katja Betts, co-CEO of PROGEN and find out why supporting the gene therapy community in developing new therapies is her everyday motivation.